Imagine if doctors could tailor cancer treatments for individual patients, training their immune system to recognise and precisely target their tumour cells without harming healthy tissue.
Hints that the removal of amyloid plaques — which are a defining feature of Alzheimer's disease — may not be essential for improving cognition, could have implications for future treatments.
In the race towards Net Zero 2050, every discovery helps. But this breakthrough could revolutionise energy production and waste consumption. This is how it occurred.
UQ is bringing together the equipment and expertise to design, manufacture and deliver mRNA vaccines that match the specific treatment needs of cancer patients.
UQ has developed a machine-learning software tool with Siemens Healthineers that offers a real-world example of AI revolutionising medicine, offering hope for patients with osteoarthritis.
UQ researchers are developing a precision-guided radiopharmaceutical solution that targets the destruction of tumours while promising more effective, patient-friendly cancer treatments